Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(24):1966-1967; doi:10.1093/jnci/92.24.1966
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Giovannucci, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giovannucci, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 24, 1966-1967, December 20, 2000
© 2000 Oxford University Press


EDITORIAL

{gamma}-Tocopherol: a New Player in Prostate Cancer Prevention?

Edward Giovannucci

Correspondence to: Edward Giovannucci, M.D., Sc.D., Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.

In this issue of the Journal, Helzlsouer et al. (1) report findings from a nested case–control study that examines plasma levels of {alpha}-tocopherol, {gamma}-tocopherol, and selenium in relation to incident prostate cancer. The study suggests protective associations for {alpha}-tocopherol and selenium, although these were not statistically significant, as well as a strong protective association with {gamma}-tocopherol. In a previous randomized intervention study designed to examine selenium supplementation in relation to recurrent skin cancer (2), a striking 65% reduction in prostate cancer risk was observed among men randomly assigned to receive selenium. In a subsequent nested case–control study (3) of 181 cases of advanced prostate cancer and 181 age-matched control pairs based on toenail selenium in the Health Professionals Follow-up Study, men in the highest quintile of selenium also had a 65% lower risk relative to those in the lowest quintile. A recent . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JCOHome page
J. M. Chan, P. H. Gann, and E. L. Giovannucci
Role of Diet in Prostate Cancer Development and Progression
J. Clin. Oncol., November 10, 2005; 23(32): 8152 - 8160.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. C.-Y. Soo, A. S. Haqqani, N. Hidiroglou, J. E. Swanson, R. S. Parker, and H. C. Birnboim
Dose-Dependent Effects of Dietary {alpha}- and {gamma}-Tocopherols on Genetic Instability in Mouse Mutatect Tumors
J Natl Cancer Inst, May 19, 2004; 96(10): 796 - 800.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Rodriguez, E. J. Jacobs, A. M. Mondul, E. E. Calle, M. L. McCullough, and M. J. Thun
Vitamin E Supplements and Risk of Prostate Cancer in U.S. Men
Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 378 - 382.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. E. Goodman, S. Schaffer, G. S. Omenn, C. Chen, and I. King
The Association between Lung and Prostate Cancer Risk, and Serum Micronutrients: Results and Lessons Learned from {beta}-Carotene and Retinol Efficacy Trial
Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 518 - 526.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. C. Malins, P. M. Johnson, E. A. Barker, N. L. Polissar, T. M. Wheeler, and K. M. Anderson
Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors
PNAS, April 29, 2003; 100(9): 5401 - 5406.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Calviello, F. Di Nicuolo, E. Piccioni, M.E. Marcocci, S. Serini, N. Maggiano, K. H. Jones, David. G. Cornwell, and P. Palozza
{gamma}-Tocopheryl quinone induces apoptosis in cancer cells via caspase-9 activation and cytochrome c release
Carcinogenesis, March 1, 2003; 24(3): 427 - 433.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
K. M. Fairfield and R. H. Fletcher
Vitamins for Chronic Disease Prevention in Adults: Scientific Review
JAMA, June 19, 2002; 287(23): 3116 - 3126.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Zhang, J. Ni, E. M. Messing, E. Chang, C.-R. Yang, and S. Yeh
Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells
PNAS, May 28, 2002; 99(11): 7408 - 7413.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Hemminki, Y. Jiang, X. Ma, K. Yang, L. Egevad, and P. Lindblad
Molecular epidemiology of VHL gene mutations in renal cell carcinoma patients: relation to dietary and other factors
Carcinogenesis, May 1, 2002; 23(5): 809 - 815.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
Q. Jiang, S. Christen, M. K Shigenaga, and B. N Ames
{gamma}-Tocopherol, the major form of vitamin E in the US diet, deserves more attention
Am. J. Clinical Nutrition, December 1, 2001; 74(6): 714 - 722.
[Abstract] [Full Text]